Found 0 matching trials
Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke
NAMedication adherence is a major factor to prevent vascular recurrence after...
Location
Service de neurologie vasculaire, Hôpital P Wertheimer, HCL
Rivaroxaban vs. Warfarin in CVT Treatment
PHASE3Cerebral venous thrombosis (CVT) is an uncommon venous-type of stroke tends...
Location
Damascus University
Stroke in Egyptian Clinical REgisTry
N/AThis is a multi-institutional registry database for the patients with strok...
Location
Alexandria University , School of medicine , Neurology Department, Neurovascular Unit
The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke
PHASE1The purpose of this study is to see whether treating subjects for wrist reh...
Location
New York Presbyterian Hospital- Weill Cornell campus
Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction
NASCENARIO is a trial to investigate the role of non-drug weight reduction in...
Location
Department of Neurology, Philipps-University Marburg
Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
PHASE2The overarching objective of the Stroke Minimization through Additive Anti-...
Location
Kwame Nkrumah University of Science & Technology
Prevention After Stroke - a Nurse-led Physician-supervised Model
NAThe study evaluates the effect of early follow up in a preventive clinic wi...
Location
Multiple Locations
Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
N/AThe hypothesis of this study is that "the poor metabolizer or intermediate ...
Location
Yongin Severance Hospital
Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion
PHASE4Intracranial artery stenosis is the leading cause of stroke onset or recurr...
Location
Second hospital of hebei medical university
JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme
PHASE3Phase III study to compare the preventive effect of recurrent brain infarct...
Location
9.178.060 Boehringer Ingelheim Investigational Site